BTG plc (BTG) Stock Rating Upgraded by Numis Securities Ltd
BTG plc (LON:BTG) was upgraded by stock analysts at Numis Securities Ltd to a “buy” rating in a research report issued on Monday. The firm presently has a GBX 900 ($11.14) price objective on the stock. Numis Securities Ltd’s price target suggests a potential upside of 29.87% from the company’s current price.
Several other analysts have also recently issued reports on the stock. Deutsche Bank AG reaffirmed a “buy” rating on shares of BTG plc in a research note on Friday, October 7th. JPMorgan Chase & Co. upped their price objective on shares of BTG plc from GBX 790 ($9.78) to GBX 830 ($10.27) and gave the company a “neutral” rating in a research note on Friday, October 7th. Stifel Nicolaus reaffirmed a “hold” rating and set a GBX 640 ($7.92) price objective on shares of BTG plc in a research note on Thursday, October 6th. Finally, Jefferies Group reaffirmed a “buy” rating and set a GBX 860 ($10.64) price objective on shares of BTG plc in a research note on Friday, July 15th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of GBX 822.86 ($10.18).
Shares of BTG plc (LON:BTG) opened at 687.50 on Monday. BTG plc has a 1-year low of GBX 504.00 and a 1-year high of GBX 739.50. The company’s market cap is GBX 2.63 billion. The stock’s 50 day moving average is GBX 637.62 and its 200 day moving average is GBX 643.12.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/17/btg-plc-btg-stock-rating-upgraded-by-numis-securities-ltd.html
In other news, insider Soderstrom,Rolf sold 74,327 shares of the company’s stock in a transaction that occurred on Thursday, July 21st. The shares were sold at an average price of GBX 676 ($8.37), for a total value of £502,450.52 ($621,844.70).
About BTG plc
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.